Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.43
PHMD's Cash to Debt is ranked higher than
55% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. PHMD: 0.43 )
PHMD' s 10-Year Cash to Debt Range
Min: 0.08   Max: No Debt
Current: 0.43

Equity to Asset 0.51
PHMD's Equity to Asset is ranked higher than
60% of the 373 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. PHMD: 0.51 )
PHMD' s 10-Year Equity to Asset Range
Min: 0.22   Max: 0.91
Current: 0.51

0.22
0.91
F-Score: 3
Z-Score: 1.30
M-Score: -2.93
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -2.40
PHMD's Operating margin (%) is ranked higher than
61% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 6.29 vs. PHMD: -2.40 )
PHMD' s 10-Year Operating margin (%) Range
Min: -7398.99   Max: 25.93
Current: -2.4

-7398.99
25.93
Net-margin (%) -1.77
PHMD's Net-margin (%) is ranked higher than
61% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 5.11 vs. PHMD: -1.77 )
PHMD' s 10-Year Net-margin (%) Range
Min: -10020.2   Max: 102.49
Current: -1.77

-10020.2
102.49
ROE (%) -2.28
PHMD's ROE (%) is ranked higher than
61% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 5.84 vs. PHMD: -2.28 )
PHMD' s 10-Year ROE (%) Range
Min: -278.85   Max: 55.77
Current: -2.28

-278.85
55.77
ROA (%) -1.64
PHMD's ROA (%) is ranked higher than
62% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 3.49 vs. PHMD: -1.64 )
PHMD' s 10-Year ROA (%) Range
Min: -128.97   Max: 22.6
Current: -1.64

-128.97
22.6
ROC (Joel Greenblatt) (%) -9.35
PHMD's ROC (Joel Greenblatt) (%) is ranked higher than
61% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 12.42 vs. PHMD: -9.35 )
PHMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -9575.16   Max: 163.98
Current: -9.35

-9575.16
163.98
Revenue Growth (%) 22.10
PHMD's Revenue Growth (%) is ranked higher than
95% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. PHMD: 22.10 )
PHMD' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 140.9
Current: 22.1

0
140.9
EBITDA Growth (%) -4.90
PHMD's EBITDA Growth (%) is ranked higher than
72% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: -2.40 vs. PHMD: -4.90 )
PHMD' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 65.7
Current: -4.9

0
65.7
EPS Growth (%) -3.50
PHMD's EPS Growth (%) is ranked higher than
72% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. PHMD: -3.50 )
PHMD' s 10-Year EPS Growth (%) Range
Min: 0   Max: 31.9
Current: -3.5

0
31.9
» PHMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

PHMD Guru Trades in Q3 2013

Joel Greenblatt 10,240 sh (New)
Chuck Royce 5,898 sh (New)
Paul Tudor Jones 10,100 sh (-7.34%)
» More
Q4 2013

PHMD Guru Trades in Q4 2013

Richard Snow 20,935 sh (New)
Paul Tudor Jones 32,200 sh (+218.81%)
Chuck Royce 5,898 sh (unchged)
Joel Greenblatt Sold Out
» More
Q1 2014

PHMD Guru Trades in Q1 2014

Richard Snow 63,995 sh (+205.68%)
Chuck Royce 5,898 sh (unchged)
Paul Tudor Jones Sold Out
» More
Q2 2014

PHMD Guru Trades in Q2 2014

Mario Gabelli 10,695 sh (New)
Richard Snow 87,365 sh (+36.52%)
Chuck Royce 5,898 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with PHMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2014-06-30 New Buy$11.81 - $15.73 $ 6.52-52%10695
Joel Greenblatt 2013-12-31 Sold Out 0.01%$11.53 - $15.78 $ 6.52-50%0
Joel Greenblatt 2013-09-30 New Buy0.01%$14.62 - $16.59 $ 6.52-59%10240
John Burbank 2012-12-31 Sold Out 0.01%$11.18 - $15.05 $ 6.52-52%0
John Burbank 2012-09-30 New Buy0.01%$10.93 - $14.55 $ 6.52-51%11371
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.80
PHMD's P/B is ranked higher than
95% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. PHMD: 0.80 )
PHMD' s 10-Year P/B Range
Min: 0.27   Max: 9.27
Current: 0.8

0.27
9.27
P/S 0.60
PHMD's P/S is ranked higher than
94% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. PHMD: 0.60 )
PHMD' s 10-Year P/S Range
Min: 0.19   Max: 9.34
Current: 0.6

0.19
9.34
EV-to-EBIT -34.02
PHMD's EV-to-EBIT is ranked higher than
52% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 37.22 vs. PHMD: -34.02 )
PHMD' s 10-Year EV-to-EBIT Range
Min: 2.8   Max: 21.7
Current: -34.02

2.8
21.7
Current Ratio 0.88
PHMD's Current Ratio is ranked lower than
55% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. PHMD: 0.88 )
PHMD' s 10-Year Current Ratio Range
Min: 0.88   Max: 9.54
Current: 0.88

0.88
9.54
Quick Ratio 0.68
PHMD's Quick Ratio is ranked lower than
54% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. PHMD: 0.68 )
PHMD' s 10-Year Quick Ratio Range
Min: 0.5   Max: 8.92
Current: 0.68

0.5
8.92

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.57
PHMD's Price/Tangible Book is ranked higher than
68% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 5.89 vs. PHMD: 5.57 )
PHMD' s 10-Year Price/Tangible Book Range
Min: 1.68   Max: 17.6
Current: 5.57

1.68
17.6
Price/DCF (Projected) 0.65
PHMD's Price/DCF (Projected) is ranked higher than
97% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 17.20 vs. PHMD: 0.65 )
PHMD' s 10-Year Price/DCF (Projected) Range
Min: 1.2   Max: 44.62
Current: 0.65

1.2
44.62
Price/Median PS Value 0.43
PHMD's Price/Median PS Value is ranked higher than
97% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 1.15 vs. PHMD: 0.43 )
PHMD' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 307.25
Current: 0.43

0.14
307.25
Earnings Yield (Greenblatt) 13.40
PHMD's Earnings Yield (Greenblatt) is ranked higher than
93% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. PHMD: 13.40 )
PHMD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.6   Max: 36.3
Current: 13.4

4.6
36.3
Forward Rate of Return (Yacktman) -6.83
PHMD's Forward Rate of Return (Yacktman) is ranked higher than
63% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.34 vs. PHMD: -6.83 )
PHMD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -48.2   Max: -5.4
Current: -6.83

-48.2
-5.4

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:LA9A.Germany, PHMD.Israel
PhotoMedex, Inc., a Nevada corporation was incorporated in December 30, 2010. The Company is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. It provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. It also offer a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. It provides dermatologists, professional aestheticians, and consumers with the equipment and skin care products they need to treat psoriasis, vitiligo, acne, and UV damage, among other skin conditions. Its three main sources of revenue generation form its three business segments: Consumer segment, Physician Recurring segment and Professional segment. The company faces competition from small, closely held, specialized aesthetic device companies, such as Dezac Group, Home Skinovations Ltd., TRIA Beauty, Inc. and LumaTherm Inc. Several public companies, such as Syneron Medical Ltd., Palomar Medical Technologies Inc. and Solta Medical, Inc., is either looking to market or are already marketing consumer aesthetics products. It also faces substantial competition from other manufacturers of surgical laser systems, whose identity varies depending on the medical application for which the surgical system is being used and from traditional surgical methods. Other companies are developing competitive surgical systems and related technologies. The Company's products and research and development activities are regulated by numerous governmental authorities, mainly the FDA and corresponding state and foreign regulatory agencies.
» More Articles for PHMD

Headlines

Articles On GuruFocus.com
Weekly 3-Year Low Highlights: GES, QLGC, NPK, PHMD, FHCO Aug 31 2014 
4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of Apr 16 2014 
Weekly CEO Sells Highlight: Tiffany & Co, Coleman Cable Inc, PhotoMedex Inc, Imax Corporation Jun 23 2013 
comment on PHMD Apr 16 2013 
comment on PHMD Apr 16 2013 
Is Photomedex Poised for a Short Squeeze? Apr 16 2013 
Weekly CEO Sells Highlight: Starbucks Corporation, Applied Materials Inc, PhotoMedex Inc, Gap Inc. Mar 10 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
PhotoMedex Inc. Reports Operating Results (10-Q) Aug 16 2010 

More From Other Websites
PHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement Aug 28 2014
PHOTOMEDEX INC Financials Aug 19 2014
PhotoMedex Inc Stock Downgraded (PHMD) Aug 15 2014
PHOTOMEDEX INC Files SEC form 10-Q, Quarterly Report Aug 11 2014
PhotoMedex downgraded by Canaccord Genuity Aug 08 2014
Why PhotoMedex (PHMD) Stock Is Plummeting Today Aug 07 2014
PhotoMedex, Inc. Earnings Call scheduled for 8:30 am ET today Aug 07 2014
PHOTOMEDEX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 07 2014
New Independent Clinical Study of no!no! Hair Shows Substantial and Statistically Significant... Aug 07 2014
PhotoMedex Reports Second Quarter Financial Results Aug 07 2014
Q2 2014 PhotoMedex, Inc. Earnings Release - Before Market Open Aug 07 2014
PhotoMedex to Hold Second Quarter 2014 Conference Call on August 7th Aug 04 2014
PHOTOMEDEX INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 31 2014
PHOTOMEDEX INC Files SEC form 8-K, Other Events Jul 30 2014
PHOTOMEDEX INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial... Jul 28 2014
Photomedex says to build on newly acquired eye surgery firm Jun 17 2014
PhotoMedex downgraded to Hold from Buy at Ascendiant May 15 2014
PhotoMedex downgraded to Hold from Buy at Maxim May 13 2014
PHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... May 13 2014
PhotoMedex's (PHMD) CEO Dolev Rafaeli on Q1 2014 Results - Earnings Call Transcript May 12 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK